Company intelligence / Profile preview

Mamotest

Corrientes, Corrientes, Argentina

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Mamotest's platform has screened over 650,000 women for breast cancer, with 87% of diagnosed patients receiving early-stage detection and timely treatment; its digital workflow enables 24-hour results, full data traceability, and significantly increases mammogram rates in underserved populations[2][3][6].

Therapeutic areas: Oncology
Modalities: DeviceArtificial Intelligence / Machine LearningSoftware and Mobile ApplicationsImaging and Sensor Technology
Industry: Medical Imaging

Partnerships

Vara (German AI platform)American Society of Clinical Oncology (ASCO) PartnersBEACON (American Cancer Society initiative)

Beyond the preview

Go deeper on Mamotest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mamotest.

Explore the full profile